BioSpace News Archive

Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the development of novel treatments for fibrosis and cancer, today announced it will present two posters at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19 in Orlando, Florida.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the company will hold a conference call and live webcast on Thursday, April 27, 2023, at 4:30 p.m. Eastern Time (ET) to review its first quarter 2023 financial results and provide a business update.

Tiziana Life Sciences Ltd. today announced it plans to investigate intranasal foralumab for the treatment of Long COVID.

University of Wisconsin-Madison, and Ginkgo Bioworks today announced a partnership to leverage Ginkgo’s proprietary high-throughput combinatorial CAR discovery and screening platform with the aim of discovering next generation GD2 CAR T-cell therapies with improved persistence, proliferation, fitness, and other functional properties to improve efficacy for the treatment of solid tumors.

Precision BioSciences, Inc. today announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for U.S. Patent Application No. 16/606,856, titled “Engineered meganucleases specific for recognition sequences in the PCSK9 gene.”

Sensei Biotherapeutics, Inc. today announced that Company management will participate in a panel titled ‘Overcoming Resistance & Immunosuppression in Solid Tumors’ at Canaccord Genuity’s Horizons in Oncology Virtual Conference on Thursday, April 20th at 3:00 p.m. ET.

Revolo Biotherapeutics announced that management will be presenting at the 8th Food Allergy Fund Summit being held on April 20, 2023, at the Paley Center for Media in New York City.

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be attending the 43rd International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions, which brings together the world’s leading experts in heart and lung transplant being held at the Colorado Convention Center, from April 19-22, in Denver, CO.

4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines

Ocean Biomedical, Inc. announced that its Scientific Co-founder and a member of its board of directors, Jonathan Kurtis, MD, PhD, received a Notice of Allowance from the United States Patent and Trademark Office for his U.S. patent application covering a therapeutic and prophylactic monoclonal antibody that kills falciparum malaria parasites.